2 completed, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Nexvax2: new trials by email Literature Review of Nexvax2 trials Research Report on Nexvax2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) Nexvax2, Placebo - Celiac Disease, Celiac | Phase 2 | Unknown | ImmusanT, Inc. | 146 | 2018-08-06 | 2019-03-19 |
| Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease Nexvax2, Placebo - Celiac Disease, Intestinal Disease | Phase 1 | Completed | ImmusanT, Inc. | 14 | 2018-05-01 | 2018-09-20 |
| Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease Nexvax2, Nexvax2 placebo - Celiac Disease | Phase 1 | Completed | ImmusanT, Inc. | 38 | 2015-08-01 | 2018-12-24 |
Celiac Disease (3) · Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Malabsorption Syndromes (2) · Autoimmune Diseases (1) · Metabolic Diseases (1)
ImmusanT, Inc. (3)
Australia (3) · New Zealand (2) · United States (1)
Robert Anderson, PhD, FRACP (2) · Robert P. Anderson, MB ChB, PhD (1)